Back to 
Woodline Partners LP
Woodline Partners LP
TGTX
Showing 7 of 22 quarters
Position history for Woodline Partners LP's holdings in TG Therapeutics, Inc.
Yes. Woodline Partners holds 715,500 shares of TGTX (TG Therapeutics), worth $39.3M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held TGTX since Q1 2026, across 2 quarterly 13F filings. TGTX is 0.1% of Woodline Partners' reported 13F portfolio.
Current Value
$39.3M
Current Shares
715,500
Total Value Change
-$20.7M
Total Shares Change
-1.8M
Quarter-by-Quarter History